Novo Nordisk’s CagriSema Falls Short, but New Pill and Longevity Data Offer a Counter-Narrative
Novo Nordisk’s stock continues to trade under a gloomy cloud, down around 46% from its 52-week high of…
Redcare Pharmacy: Short Covering and Berlin’s Margin Gambit Pull the Stock in Opposite Directions
Redcare Pharmacy shares struggle at €44.52 despite short seller retreat and strong Q1 revenue growth. Political talks on…